NeoStrata HQ Plus Lightening Gel
Produit de santé naturel homologué au Canada
L’analyse des doses orales ne s’applique pas sans voie exclusivement orale établie.
Composition
| Ingrédient médicinal et source | Par unité posologique, selon la source |
|---|---|
| Hydroquinone | 4 % (p/p) |
Ingrédients non médicinaux
Ammonia Solution, Strong NF, Chlorure de benzalkonium, Ethoxydiglycol, Eau, Hydroxyethyl Cellulose, Métabisulfite de sodium, Éthanol, Gluconolactone, Acide glycolique, propylèneglycol
Doses recommandées au Canada
| Population | Âge | Quantité par prise | Fréquence |
|---|---|---|---|
| Adultes | minimum : 20 ans | Non précisée | minimum : 1 Tous les jours ; maximum : 2 Tous les jours |
Usages autorisés au Canada
Lightens age spots and hyperpigmentation.
Un usage autorisé au Canada n'est pas une allégation de santé autorisée dans l'Union européenne. Consultez le registre des allégations de santé.
Mises en garde au Canada
- Précautions et mises en garde
To be used on the advice of a physician. For external use only. Use only as directed. Do not apply over sunburn or irritated skin. Do not apply over sunburn or irritated skin. Avoid contact with eyes, mucous membranes and broken or irritated skin. In case of contact, rinse thoroughly with water. Test for sensitivity. Apply only to small skin surface area. Discontinue use and consult a physician in case of skin reactions or a blue-black darkening of the skin. A mild transient stinging or minor redness may occur in people with sensitive skin. To test for sensitivity, before treatment, apply to area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritations occurs within 24 hours, begin treatment for up to 12 weeks. Discontinue use in case of irritation, rash, excessive inflammatory response or if a gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but when there is an excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. This product contains glycolic acid, an alpha-hydroxy acid (AHA), which may increase skin's sensitivity to the sun and particularly the possibility of sunburn. Limit sun exposure and apply a sunburn protectant while using this product and for a week afterwards. The safety of topical hydroquinone use during pregnancy or for children 12 years or less has not been established. Do not use this product if you have used it or any of its ingredients before and skin sensitivity or irritation has occurred. Do not use this product if you are nursing, pregnant or if you intended to become pregnant within 3 months of use. If you have a family history or, have or have had or are at risk of developing cancer, do not use. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of the insert before prescribing or dispensing this product. Close patient supervision is recommended. A bitter taste and anesthetic effect may occur if applied to the lips. Sunscreen use is essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Treatment should be limited to relatively small areas of the body at one time. Keep out of reach of children. Not for use on children under 12 years of age. In case of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. Note: Slight darkening of the product is normal when exposed to air and does not affect its potency. When this happens, extract a tiny amount of product, clean with a cotton swab and discard prior to use. If the entire content becomes brown, discontinue use and consult a physician. Store at room temperature.
Fiche du produit
- Titulaire
- Opella Canada Inc.
- NPN ou DIN-HM
- 02245719
- Statut
- Licence non active
- Date de licence
- 17 décembre 2007
- Date de révision
- 21 février 2014
- Forme
- Gel
- Voie d'administration
- Topique
- Type de demande
- DIN de transition
Source
Fiche officielle Santé Canada, licence 02245719
Base de données des produits de santé naturels homologués (BDPSNH), Santé Canada : produits homologués, ingrédients, doses, usages et mises en garde, consulté le 27 octobre 2026.
Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPSNH)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
La formule vendue en Europe sous le même nom peut être différente. Ces informations ne remplacent pas l'avis d'un médecin ou d'un pharmacien.
Liste dans la révision officielle du (registre Base de données des produits de santé naturels homologués (BDPSNH), Santé Canada : produits homologués, ingrédients, doses, usages et mises en garde).
Une information inexacte ou plus récente sur ce produit, que vous soyez lecteur ou marque ? Écrivez à contact@compoatlas.com : chaque correction est publiée dans le journal des corrections.
Citer cette page : CompoAtlas, « NeoStrata HQ Plus Lightening Gel », https://compoatlas.com/complements/canada/02245719-neostrata-hq-plus-lightening-gel, mise à jour le 21 février 2014.